Groupe Hospitalier du Havre
Montivilliers, Groupe Hospitalier Du Havre, 76290, France
NCT Number: NCT05492149
The aim of pulmonary rehabilitation is to improve exercise capacity and reduce dyspnoea. As well as improving the patient's overall condition, pulmonary rehabilitation provides a means to monitor the patient regularly. During physical exercise, the increased activity of the muscle system increases cardiac and respiratory output. If the patient's respiratory status deteriorates, as occurs, for example, before the onset of an exacerbation, exercise capacity could be reasonably expected to reduce. The investigators hypothesised, therefore, that changes in the physical capacity of patients with COPD during a rehabilitation session could provide a predictive indication regarding the risk of occurrence of exacerbation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montivilliers, Groupe Hospitalier Du Havre, 76290, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diary performance during rehabilitation will be collected and a CAT questionnaire will be completed by the patient.
Time frame: From admission to the program or first documented session ; to completion of the pulmonary rehabilitation program or occurrence of an exacerbation, up to 104 weeks.
The change in performance rehabilitation of patients between the last session will be screen when a patients will be admitted to hospital for a COPD exacerbation.
Time frame: Through study completion, at every pulmonary rehabilitation session ; to completion of the pulmonary rehabilitation program or occurrence of an exacerbation, up to 104 weeks.
The change in performance rehabilitation of patients between the last session will be screen and compared to a COPD Assessment Test (CAT) questionnaire score.
Groupe Hospitalier du Havre
Other
Acronym: PREDICT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04880486
COPD, COPD Exacerbation
Tainan, Taiwan
View Trial DetailsNCT04320342
COPD, COPD Exacerbation
Birmingham, Alabama, United States
View Trial DetailsNCT04481555
Azithromycin, COPD
Aarhus, Denmark
View Trial DetailsNCT05825638
Behavior, COPD
Le Havre, Normandy, France
View Trial Details